Shu Ching Lin
Direttore/Membro del Consiglio presso UNITED BIOPHARMA INC
Profilo
Shu Ching Lin is currently a Director at United BioPharma, Inc. and Shanghai Shen Lian Biomedical Corp.
She was formerly a Director at UBI Pharma Inc. She received her undergraduate and doctorate degrees from National Taiwan University.
Posizioni attive di Shu Ching Lin
| Società | Posizione | Inizio |
|---|---|---|
| UNITED BIOPHARMA INC | Direttore/Membro del Consiglio | 30/09/2013 |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Shu Ching Lin
| Società | Posizione | Fine |
|---|---|---|
| UBI PHARMA INC. | Direttore/Membro del Consiglio | - |
Formazione di Shu Ching Lin
| National Taiwan University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| UBI PHARMA INC. | Health Technology |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Shu Ching Lin
